M. Tanudra

Leveraging the Dynamic in Vitro Hollow Fiber Infection Model in Determining Optimal Clinical Dose of β-Lactam and β-Lactamase Inhibitor Combinations.

M. Tanudra, 2019 .

Coumarin-based chemosensors for zinc(II): toward the determination of the design algorithm for CHEF-type and ratiometric probes.

H. Freake, C. Brückner, M. Tanudra, 2005, Inorganic chemistry.

Selection and molecular characterization of ceftazidime/avibactam-resistant mutants in Pseudomonas aeruginosa strains containing derepressed AmpC.

R. Alm, R. Mclaughlin, James D. Whiteaker, 2015, The Journal of antimicrobial chemotherapy.

Evaluating LC-MS/MS To Measure Accumulation of Compounds within Bacteria.

A. Erwin, Tiansheng Wang, Zhengqi Ye, 2018, ACS infectious diseases.

Pharmacokinetics/pharmacodynamics of a β-lactam and β-lactamase inhibitor combination: a novel approach for aztreonam/avibactam.

A. Eakin, Renu Singh, P. Bradford, 2015, The Journal of antimicrobial chemotherapy.

Comparative In Vitro and In Vivo Efficacies of Human Simulated Doses of Ceftazidime and Ceftazidime-Avibactam against Pseudomonas aeruginosa

Virna J. A. Schuck, D. Nicolau, J. Crandon, 2012, Antimicrobial Agents and Chemotherapy.